Acurx Pharmaceuticals
ACXP
NASDAQ
IPO2021
about ACXP
Acurx Pharmaceuticals specializes in developing innovative treatments for infectious diseases, including antibiotics and antiviral therapies aimed at addressing bacterial resistance and severe viral infections.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $7.17 | $8.34 | $6.34 | $6.80M | 24.96M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$1.89 | n/a | n/a | 0% | 0% | 0% |